Between the ongoing COVID-19 pandemic and the war in Ukraine, this past year presented many challenges. And yet Medtronic continues to make progress on its environmental, social, and governance (ESG) goals.

Today, the company released its Integrated Performance Report, which recaps the company’s ESG work, including: accelerating patient access to care and health equity; creating life-transforming healthcare technologies; fostering inclusion, diversity, and equity (ID&E); and furthering environmental sustainability.

“At Medtronic, we are engineering the extraordinary for patients around the world,” said Medtronic Chairman and CEO Geoff Martha. “It’s a tremendous opportunity and responsibility we carry. The impact we’re making across all areas of our work inspires me every day as we push for even more progress.”

Did you know that in fiscal year 22, Medtronic:

• Made $97.1 million in combined philanthropic investments with the Medtronic Foundation
• Invested $2.7 billion in research and development
• Reduced greenhouse gas emissions intensity 35% compared to a FY20 baseline 
• Achieved 100% ethnically diverse and gender pay equity in the United States and 99% gender pay equity globally

To read more about the strides Medtronic made last year, please read the Integrated Performance Report.

L009 – 10112022